OneSource anticipates leading the generics market for semaglutide as multiple patents expire, expanding its capacity and ...

Canada’s public drug insurance program appears to be in limbo, with the Carney government failing to earmark any new money to ...

OTTAWA — Canada should create a pharmacare system that offers free access to essential medicines to anyone with a health card ...

With one in eight adults taking drugs like Ozempic and Mounjaro, emerging evidence shows that the medication has potential to ...

Shoppers Drug Mart billed the Ontario government’s MedsCheck program $81.2 million for medication reviews over a two-year ...

Sandoz plans to introduce unbranded Ozempic in Canada by mid-next year after Novo Nordisk's semaglutide patent expires. While no biosimilars have yet been approved, Sandoz seeks entry into the ...

DexCom's growth rate has been improving, but that hasn't been enough of a reason for investors to buy up the stock.

(Reuters) -Shares of Indian generic drugmaker Dr Reddy's Laboratories declined more than 5% on Thursday, after the firm received a non-compliance notice for its semaglutide injection in Canada, which ...

What’s more, according to a new report by the Canadian Institute for Health Information, in 2025, health care spending in Canada is on track to grow nearly two percentage points faster than the ...

Discover why Viking Therapeutics, Inc. surged 50% as GLP-1 market buzz and strong VK2735 results renew investor optimism.

Embecta (Nasdaq:EMBC) today posted fourth-quarter financial results that proved mixed compared to the consensus forecast on ...

A Garvan-led clinical trial has found that using a common and inexpensive type 2 diabetes drug reduces insulin needs in type ...